test

Oleg Nodelman

@Ecor1 Capital, Llc

Latest period2024 - Q3ReportedManaged Assets$2.922BTotal holdings63
Assets growth rate-10.62%Assets growth rate (2-Q avg)-13.97%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Ecor1 Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.

Assets under management

The assets under management (AUM) of Ecor1 Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.922B in assets, with a quarterly growth rate of -10.62% and a 2-quarter average growth rate of -13.97%. The portfolio is managed by Oleg Nodelman, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CLDXCelldex Therapeutics Inc New
Recent Activity
0.76%
$22.093M
650,000 shares@ $33.99 avg price
BCYCBicycle Therapeutics Plc
Recent Activity
0.71%
$20.593M
910,000 shares@ $22.63 avg price
IONSIonis Pharmaceuticals Inc
Recent Activity
New Position
0.69%
$20.03M
500,000 shares@ $40.06 avg price
DYNDyne Therapeutics Inc
Recent Activity
Increased 30.12%
0.69%
$19.959M
555,644 shares@ $35.92 avg price
AVIRAtea Pharmaceuticals Inc
Recent Activity
0.63%
$18.23M
5.442M shares@ $3.36 avg price
RLAYRelay Therapeutics Inc
Recent Activity
New Position
0.61%
$17.7M
2.5M shares@ $7.08 avg price
PHVSPharvaris N V
Recent Activity
0.58%
$16.668M
900,000 shares@ $18.52 avg price
ITOSIteos Therapeutics Inc
Recent Activity
Decreased -50.5%
0.57%
$16.424M
1.609M shares@ $10.21 avg price
MDGLMadrigal Pharmaceuticals Inc
Recent Activity
0.55%
$15.917M
75,000 shares@ $212.22 avg price
DAWNDay One Biopharmaceuticals I
Recent Activity
New Position
0.42%
$12.009M
862,068 shares@ $13.93 avg price